https://unauthorised investment advice/health/creso-pharmas-subsidiary-halucenexs-key-psychedelic-ingredient-passes-crucial-testing-and-is-one-step-closer-to-phase-two-clinical-trials/
- Forums
- ASX - By Stock
- Ann: Halucenex Receives Positive USP 61 and USP 62 Results
https://unauthorised investment advice/health/creso-pharmas-subsidiary-halucene...
Featured News
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some